Keywords: lundbeck, upgraded, citalopram, outlook, following, visit, company

Lundbeck upgraded on citalopram outlook

Article | 06 April 2000

Print This

Following a visit to the company, analysts at Goldman Sachs haveupgraded their earnings per share estimates by 15% for Danish company ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in